NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.

ABSTRACT: Multiple cancers regulate oxidative stress by activating the transcription factor NRF2 through mutation of its negative regulator, KEAP1. NRF2 has been studied extensively in KEAP1-mutant cancers; however, the role of this pathway in cancers with wild-type KEAP1 remains poorly understood. To answer this question, we induced NRF2 via pharmacological inactivation of KEAP1 in a panel of 50+ non-small cell lung cancer cell lines. Unexpectedly, marked decreases in viability were observed in >13% of the cell lines-an effect that was rescued by NRF2 ablation. Genome-wide and targeted CRISPR screens revealed that NRF2 induces NADH-reductive stress, through the upregulation of the NAD⁺-consuming enzyme ALDH3A1. Leveraging these findings, we show that cells treated with KEAP1 inhibitors o

SUBMITTER: Weiss-Sadan T 

PROVIDER: S-EPMC9998367 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature